Cite

HARVARD Citation

    Hansen, K. et al. (2021). Once‐weekly subcutaneous semaglutide treatment for persons with type 2 diabetes: Real‐world data from a diabetes out‐patient clinic. Diabetic medicine. 38 (10), p. n/a. [Online]. 
  
Back to record